LYCOS RETRIEVER
Mesothelioma Clinical Trial: Treatments
built 606 days ago
Clinical trials are currently ongoing in the effort to find a cure for malignant mesothelioma. These trials are made up of research studies that evaluate possible new treatments effectiveness. safely, in the hope that one day a cure will be found. Although clinical trials offer no guarantee of success and require some degree of risk, they often involve the newest technology and research. In addition, researchers do not undertake these trials without a belief that the results will have some value in treating mesothelioma. Below is a list of current treatment research.
Source:
There are three phases involved in the mesothelioma clinical trial. The first phase involves a few people to check the effectiveness of the new drug or treatment. The second phase involves a big group of people to see the side effects, safety, dosage and effectiveness of the trial. The last phase involves a massive people from the different cancer treatment centers. It can be ... said to be a comparative trial in which a comparison is conducted between the new and the existing medicine or treatment. The comparison includes the analysis of comparative risks, advantages and effects.
Source:
Mesothelioma clinical trials offer patients the opportunity to try a new treatment that is "at the cutting edge" of medicine. The treatment may help, or it may not. It's often difficult to say. There aren't any treatments that can offer a cure for mesothelioma, and standard treatments (e.g., surgery, chemotherapy, and radiation therapy) help some patients but not others. Each patient's body, medical history, and circumstances are unique, and even highly experienced medical experts can only make a best guess as to which mesothelioma clinical trials' treatments may offer the best chance of hope for a given patient.
Source:
A mesothelioma clinical trial (... clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people and ways to improve health. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
Source:
Clinical trials are supported at many organizations such as medical centers, hospitals, universities and doctors' offices. The researcher will most probably be a doctor, an academic researcher or a specialist. The researchers compare the effect of the new treatment with standard treatment. Patient receiving the clinical treatment are in a treatment group, whereas patients receiving standard treatment or no treatment are in a "control" group. Researchers assign patients randomly to either a treatment or control group. If you do not know whether you are in the treatment group or the control group, it is known as a masked study.
Source:
Clinical trials are only a small part of the research that goes into developing a new treatment. Drugs, for example, must be discovered, purified, characterized, and tested in laboratories before ever reaching clinical trials. In all, about 1,000 potential drugs are tested before just one reaches the point of being tested in a clinical trial. On average, a new cancer drug has at least 4 years of research behind it before it even makes it to clinical trials. But the major holdup in getting new cancer drugs to market is the time it takes to complete clinical trials themselves. On average, 8 years can pass from the time a cancer drug enters clinical trials until it is approved.
Source: